Does BORTEZOMIB Cause Polyomavirus-associated nephropathy? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Polyomavirus-associated nephropathy have been filed in association with BORTEZOMIB (bortezomib). This represents 0.2% of all adverse event reports for BORTEZOMIB.
77
Reports of Polyomavirus-associated nephropathy with BORTEZOMIB
0.2%
of all BORTEZOMIB reports
17
Deaths
34
Hospitalizations
How Dangerous Is Polyomavirus-associated nephropathy From BORTEZOMIB?
Of the 77 reports, 17 (22.1%) resulted in death, 34 (44.2%) required hospitalization, and 16 (20.8%) were considered life-threatening.
Is Polyomavirus-associated nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Polyomavirus-associated nephropathy?
TACROLIMUS (1,477)
MYCOPHENOLATE MOFETIL (1,112)
PREDNISONE (666)
METHYLPREDNISOLONE (416)
PREDNISOLONE (402)
BASILIXIMAB (298)
EVEROLIMUS (247)
CYCLOSPORINE (246)
MYCOPHENOLIC ACID (238)
RITUXIMAB (236)
Which BORTEZOMIB Alternatives Have Lower Polyomavirus-associated nephropathy Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX